Capricor Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Capricor Therapeutics (CAPR) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Capricor Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Capricor Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Capricor Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $1.3M | 43k | 30.40 |
| 2025-03-31 | $894k | 94k | 9.49 |
| 2024-12-31 | $1.4M | 104k | 13.80 |
| 2024-09-30 | $311k | 21k | 15.21 |
| 2024-06-30 | $54k | 11k | 4.77 |
| 2024-03-31 | $532k | 78k | 6.79 |
| 2023-12-31 | $116k | 24k | 4.89 |
| 2023-09-30 | $211k | 62k | 3.42 |
| 2020-12-31 | $3.0k | 900 | 3.33 |
| 2020-09-30 | $6.0k | 1.1k | 5.45 |
| 2020-06-30 | $5.0k | 1.1k | 4.55 |